Leda Racanicchi
Overview
Explore the profile of Leda Racanicchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
237
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhou W, Capello M, Fredolini C, Racanicchi L, Dugnani E, Piemonti L, et al.
Anal Bioanal Chem
. 2013 Mar;
405(14):4937-43.
PMID: 23508580
Pyruvate kinase (PK) is an important glycolytic enzyme that catalyzes the dephosphorylation of phosphoenolpyruvate to pyruvate. Human PK isozyme M2 (PKM2), a splice variant of M1, is overexpressed in many...
2.
Nano R, Racanicchi L, Melzi R, Mercalli A, Maffi P, Sordi V, et al.
Cell Transplant
. 2012 Oct;
22(11):2175-86.
PMID: 23051559
High levels of donor-derived high-mobility group box 1 (HMGB1) protein have been associated with poor islet graft outcome in mouse models. The aim of our work was to determine whether...
3.
Zhou W, Capello M, Fredolini C, Racanicchi L, Piemonti L, Liotta L, et al.
Electrophoresis
. 2012 Jun;
33(12):1850-4.
PMID: 22740473
L-lactate dehydrogenase (LDH) converts pyruvate to lactate when oxygen is absent or in short supply, and the enzyme plays a crucial role in cancer metabolism. The functions of many mammalian...
4.
Zhou W, Capello M, Fredolini C, Racanicchi L, Piemonti L, Liotta L, et al.
J Proteome Res
. 2011 Nov;
11(2):554-63.
PMID: 22050456
In this present work, we characterized the proteomes of pancreatic ductal adenocarcinoma (PDAC) cell line PANC-1 and normal pancreatic duct cells by mass spectrometry using LTQ-Orbitrap and identified more than...
5.
Paolino D, Cosco D, Racanicchi L, Trapasso E, Celia C, Iannone M, et al.
J Control Release
. 2010 Feb;
144(2):144-50.
PMID: 20184929
The systemic efficacy of the chemotherapeutic agents presently used to treat solid tumors is limited by their low therapeutic index. Previously, our research group improved the in vitro antitumoral activity...
6.
Racanicchi L, Basta G, Montanucci P, Guido L, Pensato A, Conti V, et al.
Tissue Eng
. 2007 Oct;
13(12):2923-31.
PMID: 17916039
Beta (beta)-cell replacement represents an attractive approach for the possible cure of type 1 insulin-dependent diabetes mellitus (IDDM). In a search for potential sources of insulin-secreting cells for IDDM substitution...
7.
Racanicchi L, Montanucci P, Basta G, Pensato A, Conti V, Calafiore R
Mol Cell Biochem
. 2007 Sep;
308(1-2):17-24.
PMID: 17899319
Human promyelocytic leukemia HL-60 cells represent an in vitro model of acute promyelocytic leukemia (APL), and are inducible to terminally differentiate into morphologically mature granulocytes by incubation with all trans...
8.
Mancuso F, Basta G, Calvitti M, Luca G, Guido L, Racanicchi L, et al.
Xenotransplantation
. 2006 Jun;
13(4):289-98.
PMID: 16768722
Background: The restricted availability of cadaveric human donor pancreases mandates validation of possibly inexhaustible, alternative sources of insulin secretory cells in order to expand islet transplant for the therapy of...
9.
Calafiore R, Basta G, Luca G, Lemmi A, Montanucci M, Calabrese G, et al.
Diabetes Care
. 2005 Dec;
29(1):137-8.
PMID: 16373911
No abstract available.
10.
Calafiore R, Basta G, Luca G, Calvitti M, Calabrese G, Racanicchi L, et al.
Biotechnol Appl Biochem
. 2004 Mar;
39(Pt 2):159-64.
PMID: 15032736
Pancreatic-islet-cell transplantation may reverse hyperglycaemia in diabetic recipients that undertake general pharmacological immunosuppression. A major challenge that remains is the need to avoid immunosuppression associated with the use of allogeneic...